Reumatologia

Scope & Guideline

Bridging academia and practice in Immunology and Allergy.

Introduction

Welcome to the Reumatologia information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Reumatologia, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN0034-6233
PublisherTERMEDIA PUBLISHING HOUSE LTD
Support Open AccessYes
CountryPoland
TypeJournal
Convergefrom 1960 to 1961, from 1963 to 2024
AbbreviationREUMATOLOGIA / Reumatologia
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressKLEEBERGA 2, POZNAN 61-615, POLAND

Aims and Scopes

The journal 'Reumatologia' focuses on the comprehensive study and management of rheumatic diseases, providing a platform for innovative research that spans clinical, epidemiological, and therapeutic domains. It emphasizes the importance of multidisciplinary approaches and patient-centered care in the field of rheumatology.
  1. Clinical Research in Rheumatology:
    The journal publishes original research articles that explore various aspects of clinical rheumatology, including diagnosis, treatment efficacy, and patient outcomes in conditions such as rheumatoid arthritis, systemic lupus erythematosus, and spondyloarthritis.
  2. Epidemiological Studies:
    It includes studies that investigate the prevalence, risk factors, and patterns associated with rheumatic diseases across different populations, contributing to a better understanding of these conditions in various demographic settings.
  3. Innovations in Treatment and Management:
    The journal highlights advancements in pharmacological and non-pharmacological treatments, including the use of biologics, DMARDs, and novel therapeutic approaches. It also covers guidelines and expert opinions on treatment protocols.
  4. Interdisciplinary Approaches:
    Research that integrates insights from psychology, nutrition, and rehabilitation into rheumatology practice is emphasized, reflecting a holistic view of patient care.
  5. Patient-Reported Outcomes and Quality of Life:
    The journal prioritizes studies that assess the impact of rheumatic diseases on patients' quality of life, exploring factors such as psychological health, social support, and treatment satisfaction.
The journal 'Reumatologia' has increasingly embraced new and relevant themes that reflect current trends in rheumatology research, showcasing a dynamic response to emerging challenges and advancements in the field.
  1. Impact of COVID-19 on Rheumatic Patients:
    Research examining the implications of COVID-19 on individuals with rheumatic diseases has surged, addressing concerns about disease management, vaccination responses, and the intersection of viral infections with autoimmune conditions.
  2. Psychosocial Factors in Rheumatology:
    There is a growing emphasis on the psychosocial aspects of rheumatic diseases, including studies on mental health, quality of life, and the influence of social determinants on disease outcomes, reflecting a holistic approach to patient care.
  3. Biologics and Targeted Therapies:
    An increase in studies focusing on the efficacy and safety of biologic treatments and targeted therapies for rheumatic diseases indicates a trend towards personalized medicine and optimizing treatment regimens.
  4. Telemedicine and Digital Health Solutions:
    The rise of telemedicine in rheumatology, particularly in response to the pandemic, is being explored, with research on its effectiveness, patient satisfaction, and impact on health outcomes.
  5. Nutritional and Lifestyle Interventions:
    Emerging research on the role of diet, exercise, and lifestyle modifications in managing rheumatic diseases highlights the importance of comprehensive, patient-centered approaches to treatment.

Declining or Waning

Over recent years, certain research themes within 'Reumatologia' have shown a decline in publication frequency, indicating a potential shift in focus among researchers and clinicians in the field.
  1. Traditional Imaging Techniques:
    There has been a noticeable decrease in studies employing conventional imaging methods for diagnosing rheumatic diseases, as newer imaging modalities (like MRI and ultrasound) are being favored for their enhanced diagnostic capabilities.
  2. Historical Perspectives:
    There seems to be a waning interest in publishing historical analyses or retrospective studies that do not contribute new insights or advancements in treatment, as the journal shifts towards more contemporary and innovative research.
  3. Basic Science Research:
    Research focusing solely on basic science aspects of rheumatology, such as molecular biology without direct clinical application, has diminished, suggesting a preference for studies that bridge laboratory findings and clinical practice.
  4. Single-Center Studies:
    The prevalence of single-center studies has decreased, with a growing emphasis on multicenter collaborations that provide broader insights and more generalizable findings in the rheumatology community.

Similar Journals

BMC Rheumatology

Unlocking potential through open-access rheumatology research.
Publisher: SPRINGERNATUREISSN: Frequency: 1 issue/year

BMC Rheumatology is a vital open-access journal that has been disseminating high-quality research in the field of rheumatology since its inception in 2017. Published by Springer Nature, this journal provides a platform for original research, reviews, and clinical studies that advance the understanding and treatment of rheumatic diseases. With a commendable impact factor and ranked in the second quartile (Q2) for Rheumatology as of 2023, BMC Rheumatology exemplifies expertise, contributing significantly to the medical community's dialogue. Researchers, professionals, and students will find valuable insights within its pages, as it caters to a diverse audience through its commitment to open-access publishing, facilitating knowledge sharing without barriers. Based in the United Kingdom and indexed in Scopus, the journal continues to thrive with a steady convergence of academic excellence through 2024, making it an indispensable resource for those dedicated to advancing rheumatological science.

Clinical Medicine Insights-Arthritis and Musculoskeletal Disorders

Exploring innovative solutions in rheumatology.
Publisher: SAGE PUBLICATIONS LTDISSN: 1179-5441Frequency: 1 issue/year

Clinical Medicine Insights-Arthritis and Musculoskeletal Disorders, published by SAGE PUBLICATIONS LTD, is an esteemed open-access journal dedicated to advancing knowledge in the field of rheumatology and related immunological disorders. Since its inception in 2008, the journal has provided a platform for researchers and clinicians from around the world to disseminate cutting-edge studies and insights into arthritis and musculoskeletal conditions. Based in New Zealand, this journal has maintained a commendable standing in academic circles, evidenced by its Q3 quartile rankings in both Immunology and Allergy and Rheumatology categories for 2023, alongside respectable Scopus rankings. The journal serves as a vital resource for healthcare professionals, researchers, and students, facilitating enhanced understanding and treatment of musculoskeletal disorders through high-quality research and peer-reviewed articles. With a focus on fostering interdisciplinary collaboration and innovation in the field, Clinical Medicine Insights-Arthritis and Musculoskeletal Disorders is essential reading for those committed to improving patient outcomes and advancing scientific knowledge.

Reumatismo

Advancing knowledge in rheumatology for a healthier future.
Publisher: PAGEPRESS PUBLISSN: 0048-7449Frequency: 4 issues/year

Reumatismo is a distinguished Open Access journal dedicated to the field of rheumatology, published by PAGEPRESS PUBL since 2001. With a rich history dating back to 1952, this journal has been pivotal in disseminating vital research on rheumatic diseases and related disorders. Based in Italy, Reumatismo has earned a reputation for its quality and relevance, achieving a Q3 category ranking in the 2023 Scopus metrics for Rheumatology, reflecting its significant contributions to the field. The journal is committed to providing a platform for the latest scientific developments and clinical innovations, thus aiding researchers, healthcare professionals, and students striving to enhance understanding and treatment of rheumatic conditions. For those seeking to access comprehensive research articles and studies, Reumatismo boasts an open access policy, ensuring that knowledge is freely available to all, fostering collaboration and advancement in rheumatology worldwide.

Advances in Rheumatology

Championing excellence in rheumatology research and practice.
Publisher: BMCISSN: 2523-3106Frequency: 1 issue/year

Advances in Rheumatology is a premier open-access journal published by BMC, dedicated to advancing the field of rheumatology through high-quality, peer-reviewed research. Launched in 2018, the journal has quickly established itself within the academic community, achieving a commendable Q2 ranking in the category of Rheumatology as of 2023 and ranking #34 out of 73 in the Scopus Medicine Rheumatology listings, placing it in the 54th percentile. With a focus on innovative treatments, patient care, and the latest in rheumatological research, the journal provides a platform for researchers and clinicians to disseminate their findings and foster collaborative advancements in this critical area of medicine. Recognized for its accessibility, the journal follows an open-access model, ensuring that research is freely available to a global audience. With a commitment to high standards of academic rigor, Advances in Rheumatology plays a vital role in enhancing the understanding and treatment of rheumatic diseases, making it an invaluable resource for researchers, professionals, and students alike.

Arthritis & Rheumatology

Exploring Breakthroughs in Arthritis and Immunology
Publisher: WILEYISSN: 2326-5191Frequency: 12 issues/year

Arthritis & Rheumatology is a leading journal dedicated to the advancement of knowledge in the fields of rheumatology, immunology, and allergy. Published by WILEY in the United Kingdom, this prestigious journal boasts an impressive impact factor and a prominent reputation, ranking in the Q1 category across multiple disciplines, including Immunology and Rheumatology. With its high ranking of 4th out of 73 in Rheumatology and notable standings in related fields, it serves as a crucial platform for researchers, healthcare professionals, and scholars to disseminate groundbreaking findings. The journal embraces an Open Access model, enhancing the accessibility of vital research to a global audience and ensuring that knowledge dissemination is maximized. Since its inception in 2014, Arthritis & Rheumatology has been at the forefront of impactful research, fostering collaboration and innovation in tackling complex challenges within these medical disciplines. Researchers looking to explore the latest advancements and engage with cutting-edge studies in these fields will find this journal to be an essential resource.

Lupus Science & Medicine

Leading the charge in lupus understanding and management.
Publisher: BMJ PUBLISHING GROUPISSN: 2053-8790Frequency: 1 issue/year

Lupus Science & Medicine is a leading open-access journal published by the BMJ Publishing Group, dedicated to advancing the understanding and treatment of lupus and related autoimmune diseases. Since its establishment in 2014, the journal has fostered an academic environment for researchers, healthcare professionals, and students, providing a platform for high-quality, evidence-based studies. With a notable impact in the fields of immunology and rheumatology, it currently holds a Q1 ranking in Rheumatology and Medicine (miscellaneous) and Q2 in Immunology, reflecting its significant contribution to these vital areas of medical research. The journal is indexed in Scopus, with a commendable rank in the 67th percentile for Rheumatology, making it a valuable resource for those seeking the latest insights into lupus management and treatment. The journal emphasizes the importance of open access, ensuring that research findings are widely available to enhance global knowledge and collaboration in the fight against lupus.

ZEITSCHRIFT FUR RHEUMATOLOGIE

Connecting researchers and clinicians for better rheumatic disease outcomes.
Publisher: SPRINGER HEIDELBERGISSN: 0340-1855Frequency: 10 issues/year

ZEITSCHRIFT FUR RHEUMATOLOGIE, published by Springer Heidelberg, serves as a vital platform in the field of rheumatology, providing researchers, clinicians, and students with cutting-edge findings and discussions related to the diagnosis, treatment, and management of rheumatic diseases. Since its inception in 1974 and continuing until 2024, this journal retains its commitment to disseminating significant scientific work within this specialized domain. Although it is currently categorized in the Q4 quartile for Rheumatology and ranks 47 out of 73 in Scopus, reflecting its burgeoning presence, the journal is dedicated to evolving and gaining prominence in the academic community. By offering valuable insights and fostering scholarly discourse, ZEITSCHRIFT FUR RHEUMATOLOGIE plays a crucial role in advancing rheumatology research and enhancing patient care practices worldwide. The journal presents an opportunity for its readers to engage with contemporary studies and enrich their understanding of rheumatic ailments.

Revista Cubana de Reumatologia

Championing open access to vital rheumatology knowledge.
Publisher: SOC CUBANA REUMATOLOGIAISSN: 1606-5581Frequency: 2 issues/year

Revista Cubana de Reumatologia is a prominent open-access journal published by the SOC CUBANA REUMATOLOGIA, dedicated to advancing knowledge in the field of rheumatology since its inception in 1998. With an ISSN of 1606-5581 and an E-ISSN of 1817-5996, this journal aims to disseminate high-quality research that addresses various aspects of rheumatic diseases, their diagnosis, treatment, and management. Located in Havana, Cuba, the journal serves as a vital platform for both local and international researchers, professionals, and students interested in the latest developments within the specialty. By embracing an open-access policy, the journal ensures that groundbreaking studies are freely available to a global audience, fostering collaboration and innovation in rheumatological research. As the field continues to evolve, Revista Cubana de Reumatologia remains committed to addressing the emerging challenges and trends, making it an essential resource for practitioners and scholars alike.

Modern Rheumatology

Empowering Professionals Through Cutting-Edge Research
Publisher: OXFORD UNIV PRESSISSN: 1439-7595Frequency: 6 issues/year

Modern Rheumatology is a premier journal dedicated to advancing the field of rheumatology through high-quality peer-reviewed research. Published by Oxford University Press, this journal reflects the latest developments in rheumatologic medicine, catering to researchers, clinicians, and students alike. With an H-Index highlighting its scholarly impact, Modern Rheumatology occupies a notable position, ranking Q2 in both the fields of Medicine and Rheumatology in 2023, and is listed among the top 25 journals in its category by Scopus. Spanning from the year 2000 to 2024, the journal features a diverse array of topics aimed at addressing current challenges and innovations in the field. Although it does not offer Open Access, it provides essential insights for professionals seeking to stay abreast of evolving treatment modalities and research breakthroughs. Located in the heart of the United Kingdom, Modern Rheumatology is a vital resource for anyone committed to enhancing the understanding and treatment of rheumatic diseases.

Lancet Rheumatology

Pioneering insights for the future of rheumatological care.
Publisher: ELSEVIERISSN: 2665-9913Frequency: 12 issues/year

The Lancet Rheumatology, published by Elsevier, is a premier academic journal dedicated to advancing the understanding of rheumatology and immunological diseases. Launched in 2019, this esteemed publication has quickly become a leading source of research, achieving an impressive Q1 ranking in both the fields of Rheumatology and Immunology as of 2023. With Scopus rankings placing it at #2 out of 73 in Medicine - Rheumatology and #6 out of 233 in Medicine - Immunology and Allergy, the journal serves as an essential platform for disseminating high-quality, peer-reviewed articles that address the latest findings and clinical practices in these domains. The journal, accessible in print and online, is committed to fostering knowledge and collaboration among researchers, healthcare professionals, and students alike, making it an invaluable resource for those seeking to deepen their expertise in rheumatology and its interrelated fields.